Business Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook – CNBC Last updated: April 30, 2026 10:38 am Editorial Staff 12 hours ago Share SHARE Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook CNBCsource Milliman analysis: March market declines end 11-month streak of corporate pension funding improvements – Bluefield Daily Telegraph Danaher Q1 2026 Earnings Update – Seeking Alpha 'Magnificent 7' stocks are seeing a shocking run: Chart – Yahoo Finance US imposes sanctions on a China-based oil refinery and 40 shippers over Iranian oil – Audacy Triumph Financial sets new metrics, has strong quarter in factoring – Yahoo Finance Share This Article Facebook Email Print Previous Article What Apple's new CEO announcement signals ahead of earnings? – Yahoo Finance UK Next Article Lincoln officials support bottle bill, recycling reform legislation – The Valley Breeze Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
